Liver transplantation outcomes for early-stage hepatocellular carcinoma: Results of a multicenter study

被引:115
作者
Leung, JY
Zhu, AX
Gordon, FD
Pratt, DS
Mithoefer, A
Garrigan, K
Terella, A
Hertl, M
Cosimi, AB
Chung, RT
机构
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Transplant Unit, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA
[6] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA
[7] Lahey Clin Fdn, Burlington, MA 01805 USA
关键词
D O I
10.1002/lt.20311
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The incidence of hepatocellular carcinoma (HCC), a frequent and incurable complication of cirrhosis, continues to rise. Orthotopic liver transplantation (OLT) has been proposed as a treatment for unresectable, intrahepatic HCC limited in extent to the Milan criteria adopted by the United Network of Organ Sharing (UNOS) in 1998. More recently, somewhat less restrictive University of California, San Francisco (UCSF)(10), criteria were proposed. To examine the long-term outcomes of OLT for HCC patients and to assess the UNOS policy of assigning weighted allocation points to patients with HCC, we retrospectively analyzed 144 patients (113 after 1998) with HCC who underwent OLT over an 11-year period at 3 institutions from UNOS Region 1. We compared their outcomes with 525 patients (272 after 1998) who underwent OLT for nonmalignant liver disease. The 1- and 5-year survival rates were 80.3% and 46.7%, respectively, for patients with HCC and 81.5% and 70.6%, respectively, for patients without HCC (P =.020). However, there was no difference in survival between HCC and non-HCC patients after implementation of disease-specific allocation for HCC in 1998. A higher proportion of the HCC cohort was older and male and had chronic HCV infection and alcoholic liver disease. In univariate analysis, having alpha-fetoprotein (AFP) levels of 10 ng/mL or less and meeting clinical and pathologic UCSF criteria were each significant predictors of improved survival (P =.005, P =.02, and P =.03, respectively). AFP greater than 10 ng/mL and exceeding pathologic UCSF criteria were also significant predictors of recurrence (P =.003 and P =.02, respectively). In conclusion, taken together, our data suggest that OLT is an acceptable option for patients with early HCC and that UCSF criteria predict outcome better than Milan or UNOS criteria. Regardless of which criteria are adopted to define eligibility, strict adherence to the criteria is important to achieve acceptable outcomes.
引用
收藏
页码:1343 / 1354
页数:12
相关论文
共 16 条
[1]   Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation [J].
Achkar, JP ;
Araya, V ;
Baron, RL ;
Marsh, JW ;
Dvorchik, I ;
Rakela, J .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (06) :477-482
[2]   Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality [J].
Baid, S ;
Cosimi, AB ;
Farrell, ML ;
Schoenfeld, DA ;
Feng, S ;
Chung, RT ;
Tolkoff-Rubin, N ;
Pascual, M .
TRANSPLANTATION, 2001, 72 (06) :1066-1072
[3]   The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update [J].
El-Serag, H ;
Davila, JA ;
Petersen, NJ ;
McGlynn, KA .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) :817-823
[4]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[5]   Increasing incidence and pretransplantation screening of hepatocellular carcinoma [J].
Everson, GT .
LIVER TRANSPLANTATION, 2000, 6 (06) :S2-S10
[6]   Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study [J].
Figueras, J ;
Jaurrieta, E ;
Valls, C ;
Benasco, C ;
Rafecas, A ;
Xiol, X ;
Fabregat, J ;
Casanovas, T ;
Torras, J ;
Baliellas, C ;
Ibanez, L ;
Moreno, P ;
Casais, L .
HEPATOLOGY, 1997, 25 (06) :1485-1489
[7]   LIVER-TRANSPLANTATION FOR PRIMARY HEPATIC CANCER [J].
HAUG, CE ;
JENKINS, RL ;
ROHRER, RJ ;
AUCHINCLOSS, H ;
DELMONICO, FL ;
FREEMAN, RB ;
LEWIS, WD ;
COSIMI, AB .
TRANSPLANTATION, 1992, 53 (02) :376-382
[8]   Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma [J].
Herrero, JI ;
Sangro, B ;
Quiroga, J ;
Pardo, F ;
Herraiz, M ;
Cienfuegos, JA ;
Prieto, J .
LIVER TRANSPLANTATION, 2001, 7 (07) :631-636
[9]   Cancer statistics, 2004 [J].
Jemal, A ;
Tiwari, RC ;
Murray, T ;
Ghafoor, A ;
Samuels, A ;
Ward, E ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) :8-29
[10]   Liver transplantation for hepatocellular carcinoma - A registry report of the impact of tumor characteristics on outcome [J].
Klintmalm, GB .
ANNALS OF SURGERY, 1998, 228 (04) :479-488